Ultrasensitive Tracking of Dual Antiparasitics in Living Tissues: UPLC-MS/MS Reveals Synergistic Distribution of Oxyclozanide and Levamisole Hydrochloride
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c05636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Guonian Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Veterinary Pharmaceutical Development, Lanzhou Institute of Husbandry and Pharma-Ceutical Sciences, Ministry of Agriculture and Rur…. Hauptthemen laut MEDLINE: Levamisole, Oxyclozanide, Antiparasitic Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Beef Cattle Industrial Technology System, Ministry of Agriculture and Rural Affairs of the People's Republic of China, Lanzhou Youth Science and Technology Talent Innovation Project.
Abstract (Originalsprache)
This study addresses the critical gap in tissue distribution kinetics of veterinary anthelmintic combination therapies by developing a novel dual-mode dynamic-switching ultraperformance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UPLC-MS/MS) method with ultrahigh sensitivity (limit of detection, LOD = 0.5 ng/g). The method enables synchronous quantification of oxyclozanide (OXY, logP = 5.69) and levamisole hydrochloride (LEV, logP = 2.32) in complex biological matrices through optimized ESI+/ESI- ionization and antiadsorption chromatographic separation (BEH C18 column). Validated per VICH GL49 and EMA/ICH guidelines, the assay demonstrated excellent linearity (2-800 ng/g, R2 > 0.990), precision (relative standard deviation, RSD ≤ 10.32%), and recovery (91.41-102.49%) across nine tissues. Spatiotemporal profiling in rats revealed distinct pharmacokinetic synergies: OXY exhibited prolonged gastric retention (maximum concentration, Cmax = 5377 ng/g, half-life, t1/2 = 32-48 h) and fecal-dominated excretion (94.58%), while LEV achieved systemic distribution with blood-brain barrier penetration (brain Cmax = 501 ng/g) and renal clearance (57.88%). The three-dimensional complementarity (spatial targeting, temporal kinetics, and clearance pathways) provides a mechanistic basis for enhanced anthelmintic efficacy and informs the optimization of withdrawal periods. This work establishes a paradigm for the preclinical evaluation of veterinary drug combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Veterinary Pharmaceutical Development, Lanzhou Institute of Husbandry and Pharma-Ceutical Sciences, Ministry of Agriculture and Rural Affairs, Chinese Academy of Agricultural Sciences, Lanzhou 730050,…
- The College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, PR China.
ORCID-Profile: Jiyu Zhang
Förderung
- National Beef Cattle Industrial Technology System
- Ministry of Agriculture and Rural Affairs of the People's Republic of China
- Lanzhou Youth Science and Technology Talent Innovation Project
Zitieren
APA
Dai, G., Zhou, Y., Xu, J., Sun, K., Li, H., Wang, Q., Li, B., Zhou, X., & Zhang, J. (2026). Ultrasensitive Tracking of Dual Antiparasitics in Living Tissues: UPLC-MS/MS Reveals Synergistic Distribution of Oxyclozanide and Levamisole Hydrochloride. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c05636
Vancouver
Dai G, Zhou Y, Xu J, Sun K, Li H, Wang Q, et al. Ultrasensitive Tracking of Dual Antiparasitics in Living Tissues: UPLC-MS/MS Reveals Synergistic Distribution of Oxyclozanide and Levamisole Hydrochloride. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c05636
BibTeX
@article{Dai2026,
author = {Dai, Guonian and Zhou, Yaxin and Xu, Jing and Sun, Kairui and Li, Haiquan and Wang, Qing and Li, Bing and Zhou, Xuzheng and Zhang, Jiyu},
title = {Ultrasensitive Tracking of Dual Antiparasitics in Living Tissues: UPLC-MS/MS Reveals Synergistic Distribution of Oxyclozanide and Levamisole Hydrochloride},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c05636}
}
EUVIMED